Artemis Medicare Services Live BSE/NSE | Artemis Medicare Services Fundamenta data | Artemis Medicare Services Balance sheet | Artemis Medicare Services Quarterly Results | Artemis Medicare Services Profit & Loss | Artemis Medicare Services Financial Ratios

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

209.16
46.84
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

291.30
N/A
0.88

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.82
6.98
3.85

EBITDA CAGR (%)

10 Years
5 Years
3 Years

13.08
7.56
0.91

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-1.14
-8.62

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 62 0 0 137 140 -2% 143 139 3% 147 0 0
Expenses 71 0 0 124 122 2% 126 122 3% 130 0 0
EBITDA -9 0 - 13 18 -28% 17 17 -2% 17 0 0
EBIDTM -14% 0% 0% 13% 12% 12% 12% 0%
Other Income 1 0 0 2 1 57% 1 1 13% 1 0 0
Interest 3 0 0 3 3 -1% 3 3 -5% 3 0 0
Depreciation 6 0 0 6 5 8% 6 5 13% 6 0 0
PBT -17 0 - 7 11 -42% 9 10 -7% 10 0 0
Tax -6 0 - 2 6 -61% 3 5 -31% 4 0 0
PAT -12 0 - 4 6 -22% 6 5 16% 6 0 0
PATM -19% 0% 3% 4% 4% 4% 4% 0%
EPS -8.75 0.00 - 3.40 4.37 -22% 4.30 3.72 16% 4.43 0.00 0

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 138 140 -1% 144 139 3% 0 0 0
Expenses 0 0 0 126 122 3% 127 122 4% 0 0 0
EBITDA 0 0 0 13 18 -28% 17 17 -3% 0 0 0
EBIDTM 0% 0% 14% 13% 12% 12% 0% 0%
Other Income 0 0 0 2 1 56% 1 1 14% 0 0 0
Interest 0 0 0 3 3 3% 3 3 -1% 0 0 0
Depreciation 0 0 0 6 5 10% 6 5 15% 0 0 0
PBT 0 0 0 6 11 -43% 9 10 -12% 0 0 0
Tax 0 0 0 2 6 -63% 3 5 -38% 0 0 0
PAT 0 0 0 4 5 -23% 6 5 14% 0 0 0
PATM 0% 0% 7% 4% 4% 4% 0% 0%
EPS 0.00 0.00 0 3.20 4.15 -23% 4.23 3.72 14% 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales - 563 546 503 459 402 367 261 217 190 154 Net Sales Growth - 3% 9% 10% 14% 9% 41% 20% 15% 23% Cost Of Goods Sold - 138 131 122 120 106 98 72 62 58 44 Gross Profit - 425 416 381 339 295 269 190 155 131 111 GP Margin - 75% 76% 76% 74% 74% 73% 73% 72% 69% 72% Total Expenditure - 501 482 443 407 359 325 234 194 166 136 Power & Fuel Cost - 10 11 11 11 11 11 11 8 7 5 % Of Sales - 2% 2% 2% 2% 3% 3% 4% 4% 3% 4% Employee Cost - 102 97 90 77 70 57 47 43 31 24 % Of Sales - 18% 18% 18% 17% 17% 16% 18% 20% 16% 16% Manufacturing Exp. - 228 220 198 169 147 132 86 7 56 48 % Of Sales - 40% 40% 39% 37% 37% 36% 33% 3% 30% 31% General & Admin Exp. - 16 20 20 23 23 22 17 12 13 14 % Of Sales - 3% 4% 4% 5% 6% 6% 6% 5% 7% 9% Selling & Distn. Exp. - 0 0 0 0 0 0 0 0 0 0 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 6 4 2 6 1 5 1 64 1 0 % Of Sales - 1% 1% 0% 1% 0% 1% 0% 29% 0% 0% EBITDA - 62 64 59 52 43 42 27 23 23 18 EBITDA Margin - 11% 12% 12% 11% 11% 11% 11% 10% 12% 12% Other Income - 5 4 4 5 5 3 1 2 2 3 Interest - 13 11 9 9 9 12 13 15 16 16 Depreciation - 22 20 18 15 12 12 9 9 9 9 PBT - 32 37 35 32 27 21 7 0 0 -4 Tax - 12 17 9 5 6 2 0 0 0 0 Tax Rate - 36% 44% 25% 16% 21% 12% 0% 0% 17% 0% PAT - 20 21 27 27 22 19 7 0 0 -4 PAT before Minority Interest - 20 21 27 27 22 19 7 0 0 -4 Minority Interest - 0 0 0 0 0 0 0 0 0 0 PAT Margin - 4% 4% 5% 6% 5% 5% 3% 0% 0% -2% PAT Growth - -2% -22% -1% 25% 16% 177% 1,714% 95% 105% EPS - 15.48 15.73 20.28 20.51 16.39 14.08 5.08 0.28 0.14 -2.74

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

563

546

503

459

402

367

261

217

190

154

Net Sales Growth

10%

14%

41%

20%

15%

23%

Cost Of Goods Sold

138

131

122

120

106

Gross Profit

425

416

381

339

295

269

190

155

131

111

GP Margin

75%

76%

74%

73%

72%

69%

72%

Total Expenditure

501

482

443

407

359

325

234

194

166

136

Power & Fuel Cost

% Of Sales

Employee Cost

102

% Of Sales

18%

17%

16%

18%

20%

16%

Manufacturing Exp.

228

220

198

169

147

132

% Of Sales

40%

39%

37%

36%

33%

30%

31%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

29%

EBITDA

EBITDA Margin

11%

12%

11%

10%

12%

Other Income

Interest

Depreciation

PBT

-4

Tax

Tax Rate

36%

44%

25%

16%

21%

12%

17%

PAT

-4

PAT before Minority Interest

-4

Minority Interest

PAT Margin

-2%

PAT Growth

-2%

-22%

-1%

25%

16%

177%

1,714%

95%

105%

EPS

15.48

15.73

20.28

20.51

16.39

14.08

5.08

0.28

0.14

-2.74

Description TTM Mar 20
Net Sales - 565 Net Sales Growth - Cost Of Goods Sold - 139 Gross Profit - 426 GP Margin - 75% Total Expenditure - 504 Power & Fuel Cost - 10 % Of Sales - 2% Employee Cost - 103 % Of Sales - 18% Manufacturing Exp. - 228 % Of Sales - 40% General & Admin Exp. - 17 % Of Sales - 3% Selling & Distn. Exp. - 0 % Of Sales - 0% Miscellaneous Exp. - 6 % Of Sales - 1% EBITDA - 61 EBITDA Margin - 11% Other Income - 5 Interest - 13 Depreciation - 23 PBT - 31 Tax - 11 Tax Rate - 36% PAT - 20 PAT before Minority Interest - 19 Minority Interest - 0 PAT Margin - 4% PAT Growth - EPS - 14.99

Description

TTM

Mar 20

Net Sales

565

Net Sales Growth

Cost Of Goods Sold

139

Gross Profit

426

GP Margin

75%

Total Expenditure

504

Power & Fuel Cost

% Of Sales

Employee Cost

103

% Of Sales

18%

Manufacturing Exp.

228

% Of Sales

40%

General & Admin Exp.

% Of Sales

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

11%

Other Income

Interest

Depreciation

PBT

Tax

Tax Rate

36%

PAT

PAT before Minority Interest

Minority Interest

PAT Margin

PAT Growth

EPS

14.99

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 314 252 231 204 184 156 137 130 130 87 Share Capital 13 21 21 21 21 21 21 21 21 18 Total Reserves 301 231 210 183 163 135 116 109 109 69 Non-Current Liabilities 110 84 73 84 56 63 89 94 93 160 Secured Loans 61 53 52 65 50 39 66 80 88 110 Unsecured Loans 0 0 0 1 0 19 19 12 5 50 Long Term Provisions 6 5 4 3 2 1 1 1 0 0 Current Liabilities 157 173 147 134 105 113 88 63 62 37 Trade Payables 74 74 67 62 55 52 42 24 16 19 Other Current Liabilities 63 53 69 56 36 47 45 34 39 18 Short Term Borrowings 11 38 0 0 0 0 0 4 7 0 Short Term Provisions 9 9 11 16 13 14 0 0 0 0 Total Liabilities 581 509 452 422 345 331 313 287 286 284 Net Block 387 337 309 283 249 239 236 237 239 243 Gross Block 461 390 341 379 331 309 293 286 278 273 Accumulated Depreciation 74 52 33 97 82 70 57 48 39 30 Non Current Assets 464 399 365 334 268 254 254 251 247 247 Capital Work in Progress 56 49 43 27 1 0 0 0 0 0 Non Current Investment 2 0 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 19 11 6 23 17 14 18 14 8 0 Other Non Current Assets 1 1 6 1 0 0 0 0 0 4 Current Assets 117 111 87 88 76 77 59 36 38 37 Current Investments 0 0 0 0 0 0 0 0 0 0 Inventories 11 7 6 6 6 7 5 4 5 4 Sundry Debtors 77 78 56 60 54 40 29 24 23 14 Cash & Bank 15 11 12 10 6 24 21 5 4 15 Other Current Assets 14 12 11 6 10 7 4 3 6 3 Short Term Loans & Adv. 2 2 2 6 6 4 1 1 0 0 Net Current Assets -40 -62 -60 -45 -28 -35 -28 -27 -24 0 Total Assets 581 509 452 422 345 331 313 287 286 284

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

314

252

231

204

184

156

137

130

Share Capital

Total Reserves

301

231

210

183

163

135

116

109

Non-Current Liabilities

110

160

Secured Loans

110

Unsecured Loans

Long Term Provisions

Current Liabilities

157

173

147

134

105

113

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

581

509

452

422

345

331

313

287

286

284

Net Block

387

337

309

283

249

239

236

237

239

243

Gross Block

461

390

341

379

331

309

293

286

278

273

Accumulated Depreciation

Non Current Assets

464

399

365

334

268

254

251

247

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

117

111

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-40

-62

-60

-45

-28

-35

-28

-27

-24

Total Assets

581

509

452

422

345

331

313

287

286

284

Description Mar 20
Shareholder's Funds 313 Share Capital 13 Total Reserves 300 Non-Current Liabilities 115 Secured Loans 66 Unsecured Loans 0 Long Term Provisions 6 Current Liabilities 158 Trade Payables 75 Other Current Liabilities 63 Short Term Borrowings 11 Short Term Provisions 9 Total Liabilities 586 Net Block 393 Gross Block 467 Accumulated Depreciation 74 Non Current Assets 469 Capital Work in Progress 56 Non Current Investment 0 Long Term Loans & Adv. 19 Other Non Current Assets 1 Current Assets 118 Current Investments 0 Inventories 11 Sundry Debtors 77 Cash & Bank 16 Other Current Assets 15 Short Term Loans & Adv. 2 Net Current Assets -40 Total Assets 586

Description

Mar 20

Shareholder's Funds

313

Share Capital

Total Reserves

300

Non-Current Liabilities

115

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

158

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

586

Net Block

393

Gross Block

467

Accumulated Depreciation

Non Current Assets

469

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

118

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-40

Total Assets

586

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 56 41 72 58 20 53 45 22 7 16 PBT 32 37 35 32 27 21 7 0 0 -4 Adjustment 33 26 14 19 15 23 22 24 23 23 Changes in Working Capital -5 -13 24 8 -21 10 11 -3 -17 -1 Cash after chg. in Working capital 61 51 73 59 21 54 40 21 7 18 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -4 -10 -1 -1 0 -1 5 2 0 -2 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -22 -50 -67 -74 -14 -10 -12 -5 4 0 Net Fixed Assets -78 -55 22 -74 -23 -16 -7 -8 -5 -73 Net Investments -2 0 0 0 0 0 0 0 0 0 Others 58 5 -89 0 9 6 -5 2 9 73 Cash from Financing Activity -33 14 -10 19 -24 -35 -21 -18 -13 -11 Net Cash Inflow / Outflow 2 5 -4 3 -18 7 11 -1 -3 4 Opening Cash & Equivalents 9 3 7 4 22 14 4 4 7 11 Closing Cash & Equivalent 11 8 3 7 4 22 14 4 4 15

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

PBT

-4

Adjustment

Changes in Working Capital

-5

-13

-21

-3

-17

-1

Cash after chg. in Working capital

Interest Paid

Tax Paid

-4

-10

-1

-2

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-22

-50

-67

-74

-14

-10

-12

-5

Net Fixed Assets

-78

-55

-74

-23

-16

-7

-8

-5

-73

Net Investments

-2

Others

-89

-5

Cash from Financing Activity

-33

-10

-24

-35

-21

-18

-13

-11

Net Cash Inflow / Outflow

-4

-18

-1

-3

Opening Cash & Equivalents

Closing Cash & Equivalent

Description Mar 20
Cash From Operating Activity 56 PBT 31 Adjustment 34 Changes in Working Capital -4 Cash after chg. in Working capital 60 Interest Paid 0 Tax Paid -4 Other Direct Exp. Paid 0 Extra & Other Items 0 Cash From Investing Activity -26 Net Fixed Assets Net Investments Others Cash from Financing Activity -27 Net Cash Inflow / Outflow 2 Opening Cash & Equivalents 9 Closing Cash & Equivalent 12

Description

Mar 20

Cash From Operating Activity

PBT

Adjustment

Changes in Working Capital

-4

Cash after chg. in Working capital

Interest Paid

Tax Paid

-4

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-26

Net Fixed Assets

Net Investments

Others

Cash from Financing Activity

-27

Net Cash Inflow / Outflow

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone /

Consolidated

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 187 88 79 66 50 40 31 28 28 9 ROA 4% 4% 6% 7% 6% 6% 2% 0% 0% -1% ROE 9% 12% 18% 22% 23% 25% 11% 1% 1% -21% ROCE 13% 17% 18% 21% 21% 19% 11% 9% 10% 7% Fixed Asset Turnover 1.26 1.50 1.40 1.29 1.26 1.22 0.90 0.77 0.69 0.65 Receivable days 50 45 42 45 42 34 37 39 36 28 Inventory Days 6 4 5 5 6 6 7 8 9 11 Payable days 54 54 53 54 56 56 54 57 40 49 Cash Conversion Cycle 2 -5 -7 -4 -8 -15 -11 -10 5 -10 Total Debt/Equity 0.37 0.61 0.55 0.67 0.64 1.02 1.69 2.02 1.71 10.62 Interest Cover 4 4 5 4 4 3 2 1 1 1

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

187

ROA

-1%

ROE

12%

18%

22%

23%

25%

11%

-21%

ROCE

13%

17%

18%

21%

19%

11%

10%

Fixed Asset Turnover

1.26

1.50

1.40

1.29

1.26

1.22

0.90

0.77

0.69

0.65

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

-5

-7

-4

-8

-15

-11

-10

Total Debt/Equity

0.37

0.61

0.55

0.67

0.64

1.02

1.69

2.02

1.71

10.62

Interest Cover

Description Mar 20
Book Value (Rs.) 187 ROA 3% ROE 8% ROCE 13% Fixed Asset Turnover 1.25 Receivable days 50 Inventory Days 6 Payable days 54 Cash Conversion Cycle 2 Total Debt/Equity 0.40 Interest Cover 3

Artemis Medicare Services Ltd.

Hospital & Healthcare Services

BSE: 542919 | NSE: ARTEMISMED

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update

Artemis Medicare Services Ltd.

Hospital & Healthcare Services

BSE: 542919 | NSE: ARTEMISMED

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Annual Reports:

News Update